Zdrowie i gospodarka · 10/10/2018

FDA Requests Comments on Scheduling of 16 Drug Substances

The US Food and Drug Administration (FDA) is seeking public input on the scheduling of 16 pharmaceutical substances, including ADB-FUBINACA, ADB-CHMINACA, and Tramadol, to inform the US response to the World Health Organization's consideration of international restrictions on these substances.